Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Full article: POSTER PRESENTATIONS

Impact of Comorbidities on Disease Activity, Patient Global

Assessment and Monitoring, Ankylosing Spondylitis

Real-world effectiveness of golimumab in adult patients with

Poster Abstract Presentation Abstracts - 2023 - International

Safety Profile, Axial Spondyloarthritis

Performance of 3 Composite Measures for Disease Activity in

PDF) Development and preselection of criteria for short term

PDF) AB0002 Sirt-1 Activity in PBMC from Patients with

Which Disease Activity Outcome Measure Discriminates Best in Axial